T-cell clone associated with efalizumab therapy.
Lynch
M
M
Murphy
K
K
Slaby
J
J
Kirby
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001402:B-Lymphocytes / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology*; D006801:Humans; D008218:Lymphocytosis / Q000139:chemically induced*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab